STOCK TITAN
  1. Home
  2. BHICD

BioScience Health Innovations (BHICD) Stock Price, News & Analysis

BHICD OTC
Published by Stock Titan Data refreshed

What Changed

Company Description

For FY2025, BioScience Health Innovations reported revenue of $5.7M with net income of $642K and diluted earnings per share of $0.06. The company operates at a net profit margin of 11.3%.

This page collects what Stock Titan holds for BHICD, including price data, SEC filings, and financial highlights.

Stock Performance

Chart
—
-
-
-
Performance 1 year
-
Market Cap
-
Shares outstanding

BHICD Metrics & Rankings

Revenue
$5.7M
#3,646
Piotroski F-Score
5/7 Partial
#1,980

Latest News

View All

No recent news available for BHICD.

SEC Filings

View All

[10-Q] BioScience Health Innovations (BHIC) swings to Q1 2026 loss as revenue falls

[8-K] Bioscience Health Innovations (BHIC) CTO Daniel Schmidt joins board after director exit

[10-K] BioScience Health Innovations (OTC: BHIC) triples revenue and boosts profit on MODS Max platform

[10-Q] BHIC posts $4.12M YTD revenue and positive cash flow; control weaknesses flagged

[8-K] BHIC 1-for-4 reverse split approved by board and majority holders

BioScience Health Innovations has filed 5 recent SEC filings, including 2 Form 10-Q, 2 Form 8-K, 1 Form 10-K. The most recent filing was submitted on . SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all BHICD SEC filings →

Financial Highlights

View Full Financials

BioScience Health Innovations generated $5.7M in revenue in FY2025, retaining a 57.0% gross margin, operating income reached $719K (12.6% operating margin), and net income was $642K, reflecting a 11.3% net profit margin. Diluted earnings per share stood at $0.06. The company generated $172K in operating cash flow.

$5.7M
Revenue (FY2025)
$642K
Net Income (FY2025)
$0.06
Diluted EPS (FY2025)
$172K
Operating Cash Flow
11.3%
Net Profit Margin
12.6%
Oper. Profit Margin

Upcoming Events

No upcoming events scheduled for BHICD.

Frequently Asked Questions

The FY2025 revenue of BioScience Health Innovations (BHICD) is $5.7M, from its most recent completed fiscal year.

The FY2025 net income of BioScience Health Innovations (BHICD) is $642K, from its most recent completed fiscal year.

The diluted earnings per share (EPS) of BioScience Health Innovations (BHICD) is $0.06 for FY2025, its most recent completed fiscal year. Learn more about EPS .

The operating cash flow of BioScience Health Innovations (BHICD) is $172K for FY2025, its most recent completed fiscal year. Learn about cash flow.

The net profit margin of BioScience Health Innovations (BHICD) is 11.3% for FY2025, its most recent completed fiscal year. Learn about profit margins.

The operating profit margin of BioScience Health Innovations (BHICD) is 12.6% for FY2025, its most recent completed fiscal year. Learn about operating margins.

The gross profit margin of BioScience Health Innovations (BHICD) is 57.0% for FY2025, its most recent completed fiscal year. Learn about gross margins.

The gross profit of BioScience Health Innovations (BHICD) is $3.2M for FY2025, its most recent completed fiscal year.

The operating income of BioScience Health Innovations (BHICD) is $719K for FY2025, its most recent completed fiscal year. Learn about operating income.